Home
CSTL
CSTL News

Latest Castle Biosciences Inc. (CSTL) News on July 26, 2024

Investors in Castle Biosciences (NASDAQ:CSTL) have unfortunately lost 71% over the last three years

Simply Wall St.

a day ago

Investors in Castle Biosciences (NASDAQ:CSTL) have unfortunately lost 71% over the last three years

Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion

Zacks

4 days ago

Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion

Castle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of Melanoma

Business Wire

5 days ago

Castle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of Melanoma

5 Top Small Cap Stocks to Buy Now

Zacks

7 days ago

5 Top Small Cap Stocks to Buy Now

Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024

Business Wire

12 days ago

Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024

All You Need to Know About Castle Biosciences (CSTL) Rating Upgrade to Strong Buy

Zacks

14 days ago

All You Need to Know About Castle Biosciences (CSTL) Rating Upgrade to Strong Buy

Castle Biosciences Honored with Top Workplaces Awards

Business Wire

16 days ago

Castle Biosciences Honored with Top Workplaces Awards

Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® Test

Business Wire

a month ago

Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® Test

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a month ago

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner

Business Wire

a month ago

Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner

Is Castle Biosciences (CSTL) Outperforming Other Medical Stocks This Year?

Zacks

a month ago

Is Castle Biosciences (CSTL) Outperforming Other Medical Stocks This Year?

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

2 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

2 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

2 months ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

2 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

2 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

2 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

2 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

2 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance

Business Wire

2 months ago

Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance

New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis

Business Wire

2 months ago

New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis

Does Castle Biosciences (CSTL) Have the Potential to Rally 36.15% as Wall Street Analysts Expect?

Zacks

2 months ago

Does Castle Biosciences (CSTL) Have the Potential to Rally 36.15% as Wall Street Analysts Expect?

What Makes Castle Biosciences (CSTL) a Good Fit for 'Trend Investing'

Zacks

2 months ago

What Makes Castle Biosciences (CSTL) a Good Fit for 'Trend Investing'

Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference

Business Wire

2 months ago

Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference

Castle Biosciences Expands Evidence Supporting the Performance of its TissueCypher® Barrett’s Esophagus Test in Predicting Future Development of Esophageal Cancer Through Multiple Data Presentations at DDW 2024

Business Wire

2 months ago

Castle Biosciences Expands Evidence Supporting the Performance of its TissueCypher® Barrett’s Esophagus Test in Predicting Future Development of Esophageal Cancer Through Multiple Data Presentations at DDW 2024

Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for "Best Overall Mental Health Solution"

Business Wire

3 months ago

Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for "Best Overall Mental Health Solution"

MT Newswires

3 months ago

Castle Biosciences Insider Sold Shares Worth $574,679, According to a Recent SEC Filing

Largest Prospective Study to Date Further Supports Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with DecisionDx-UM Class Result

Business Wire

3 months ago

Largest Prospective Study to Date Further Supports Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with DecisionDx-UM Class Result

Wall Street Analysts Predict a 36.09% Upside in Castle Biosciences (CSTL): Here's What You Should Know

Zacks

3 months ago

Wall Street Analysts Predict a 36.09% Upside in Castle Biosciences (CSTL): Here's What You Should Know

Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

3 months ago

Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable

Earnings Beat: Castle Biosciences, Inc. (NASDAQ:CSTL) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.

3 months ago

Earnings Beat: Castle Biosciences, Inc. (NASDAQ:CSTL) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript

DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck

Business Wire

3 months ago

DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck

Castle Biosciences Inc (CSTL) Q1 2024 Earnings: Surpasses Revenue Forecasts and Raises Annual ...

GuruFocus.com

3 months ago

Castle Biosciences Inc (CSTL) Q1 2024 Earnings: Surpasses Revenue Forecasts and Raises Annual ...

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates

Zacks

3 months ago

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates

Castle Biosciences Reports First Quarter 2024 Results

Business Wire

3 months ago

Castle Biosciences Reports First Quarter 2024 Results

Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood’s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma

Business Wire

3 months ago

Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood’s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma

We're Not Worried About Castle Biosciences' (NASDAQ:CSTL) Cash Burn

Simply Wall St.

3 months ago

We're Not Worried About Castle Biosciences' (NASDAQ:CSTL) Cash Burn

Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024

Business Wire

4 months ago

Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024

Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations

Business Wire

4 months ago

Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations

Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year

Business Wire

4 months ago

Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year

What Makes Castle Bioscience (CSTL) a Prospective Investment?

Insider Monkey

4 months ago

What Makes Castle Bioscience (CSTL) a Prospective Investment?

Presentations at EADO Highlight Potential Impact of Castle Biosciences’ DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer

Business Wire

4 months ago

Presentations at EADO Highlight Potential Impact of Castle Biosciences’ DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer

Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Business Wire

4 months ago

Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Business Wire

4 months ago

Castle Biosciences Announces Updates to its Board of Directors

Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year

Business Wire

4 months ago

Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year

Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB

Business Wire

4 months ago

Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB

Does Castle Bioscience (CSTL) Have Robust Growth Prospects?

Insider Monkey

4 months ago

Does Castle Bioscience (CSTL) Have Robust Growth Prospects?

Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy

Business Wire

4 months ago

Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy

New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older

Business Wire

4 months ago

New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older

Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Business Wire

5 months ago

Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting

Business Wire

5 months ago

Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting

In Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroups

Business Wire

5 months ago

In Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroups

Castle Biosciences, Inc. (NASDAQ:CSTL) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Simply Wall St.

5 months ago

Castle Biosciences, Inc. (NASDAQ:CSTL) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Castle Biosciences Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Castle Biosciences Full Year 2023 Earnings: Beats Expectations

Castle Biosciences, Inc. (NASDAQ:CSTL): Are Analysts Optimistic?

Simply Wall St.

5 months ago

Castle Biosciences, Inc. (NASDAQ:CSTL): Are Analysts Optimistic?

Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Castle Biosciences Inc Earnings Call

Castle Biosciences, Inc. (CSTL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

5 months ago

Castle Biosciences, Inc. (CSTL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates

Zacks

5 months ago

Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates

Castle Biosciences Inc (CSTL) Reports Robust Revenue Growth and Improved Margins in 2023

GuruFocus.com

5 months ago

Castle Biosciences Inc (CSTL) Reports Robust Revenue Growth and Improved Margins in 2023

Business Wire

5 months ago

Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results

Insights Into Castle Biosciences, Inc. (CSTL) Q4: Wall Street Projections for Key Metrics

Zacks

5 months ago

Insights Into Castle Biosciences, Inc. (CSTL) Q4: Wall Street Projections for Key Metrics

Study Finds DecisionDx®-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I Melanoma Compared to American Joint Committee on Cancer 8th Edition Staging

Business Wire

5 months ago

Study Finds DecisionDx®-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I Melanoma Compared to American Joint Committee on Cancer 8th Edition Staging

Strength Seen in Alector (ALEC): Can Its 6.0% Jump Turn into More Strength?

Zacks

6 months ago

Strength Seen in Alector (ALEC): Can Its 6.0% Jump Turn into More Strength?

Castle Biosciences to Release Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call on Wednesday, Feb. 28, 2024

Business Wire

6 months ago

Castle Biosciences to Release Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call on Wednesday, Feb. 28, 2024

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Zacks Analyst Blog Highlights Yum! Brands, Hexcel, Arthur J. Gallagher, United Rentals and Heritage Financial

Zacks

6 months ago

The Zacks Analyst Blog Highlights Yum! Brands, Hexcel, Arthur J. Gallagher, United Rentals and Heritage Financial

Associated Press Finance

6 months ago

Columbus McKinnon: Fiscal Q3 Earnings Snapshot

Columbus McKinnon Reports 33% Operating Income Growth on 10% Net Sales Growth for Third Quarter Fiscal Year 2024

Business Wire

6 months ago

Columbus McKinnon Reports 33% Operating Income Growth on 10% Net Sales Growth for Third Quarter Fiscal Year 2024

Tompkins Financial Corp Reports Decline in Q4 Earnings Amid Rising Costs

GuruFocus.com

6 months ago

Tompkins Financial Corp Reports Decline in Q4 Earnings Amid Rising Costs

Interface, Inc. to Host Fourth Quarter and Fiscal Year 2023 Results Conference Call on February 27, 2024

Business Wire

6 months ago

Interface, Inc. to Host Fourth Quarter and Fiscal Year 2023 Results Conference Call on February 27, 2024

Chief Commercial Officer Matt Prusak leaving Hut 8 as part of planned transition to Celsius Bitcoin mining company

GlobeNewswire

6 months ago

Chief Commercial Officer Matt Prusak leaving Hut 8 as part of planned transition to Celsius Bitcoin mining company

Q3 Earnings Roundup: Boston Beer (NYSE:SAM) And The Rest Of The Beverages and Alcohol Segment

StockStory

6 months ago

Q3 Earnings Roundup: Boston Beer (NYSE:SAM) And The Rest Of The Beverages and Alcohol Segment

Forward Air-Omni merger finally closes

FreightWaves

6 months ago

Forward Air-Omni merger finally closes

SL Green Realty Corp (SLG) Reports Mixed Results for Q4 2023 Amidst Non-Recurring Charges

GuruFocus.com

6 months ago

SL Green Realty Corp (SLG) Reports Mixed Results for Q4 2023 Amidst Non-Recurring Charges

Ribbon Honored with "Rise and Shine" Award from MTN GSSC - Global Sourcing and Supply Chain

CNW Group

6 months ago

Ribbon Honored with "Rise and Shine" Award from MTN GSSC - Global Sourcing and Supply Chain

Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments

GlobeNewswire

6 months ago

Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments

Associated Press Finance

6 months ago

The First Bancshares: Q4 Earnings Snapshot

The First Bancshares, Inc. Reports Results for Fourth Quarter ended December 31, 2023; Increases Quarterly Dividend 4%

Business Wire

6 months ago

The First Bancshares, Inc. Reports Results for Fourth Quarter ended December 31, 2023; Increases Quarterly Dividend 4%

With 60% institutional ownership, Ares Acquisition Corporation II (NYSE:AACT) is a favorite amongst the big guns

Simply Wall St.

6 months ago

With 60% institutional ownership, Ares Acquisition Corporation II (NYSE:AACT) is a favorite amongst the big guns

Ducommun, the Los Angeles Chargers and University of California, Irvine Mark Sixth Anniversary of STEM on the SidelinesTM Initiative Promoting Science, Technology, Engineering and Mathematics Among Southern California High Schools

GlobeNewswire

6 months ago

Ducommun, the Los Angeles Chargers and University of California, Irvine Mark Sixth Anniversary of STEM on the SidelinesTM Initiative Promoting Science, Technology, Engineering and Mathematics Among Southern California High Schools

Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks

GlobeNewswire

6 months ago

Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks

Eaton Vance Enhanced Equity Income Fund II's Dividend Analysis

GuruFocus.com

6 months ago

Eaton Vance Enhanced Equity Income Fund II's Dividend Analysis

Eaton Vance Tax-Mgd Glbl Div Eq Inc's Dividend Analysis

GuruFocus.com

6 months ago

Eaton Vance Tax-Mgd Glbl Div Eq Inc's Dividend Analysis

EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND's Dividend Analysis

GuruFocus.com

6 months ago

EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND's Dividend Analysis

Coeur Mining (CDE) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zacks

6 months ago

Coeur Mining (CDE) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Coeur to Participate in Upcoming TD Securities Global Mining Conference

Business Wire

6 months ago

Coeur to Participate in Upcoming TD Securities Global Mining Conference

New Study Highlights Significant Potential Medicare Savings Through Use of Castle Biosciences’ DecisionDx®-SCC Test to Guide Adjuvant Radiation Therapy Decisions in Patients with Cutaneous Squamous Cell Carcinoma

Business Wire

6 months ago

New Study Highlights Significant Potential Medicare Savings Through Use of Castle Biosciences’ DecisionDx®-SCC Test to Guide Adjuvant Radiation Therapy Decisions in Patients with Cutaneous Squamous Cell Carcinoma

Dime Community Bancshares to Release Earnings on January 26, 2024

GlobeNewswire

6 months ago

Dime Community Bancshares to Release Earnings on January 26, 2024

IMAX Names Anne Globe as Chief Marketing Officer

PR Newswire

6 months ago

IMAX Names Anne Globe as Chief Marketing Officer

Gladstone Land Announces Gain on Sale of Florida Farm

ACCESSWIRE

6 months ago

Gladstone Land Announces Gain on Sale of Florida Farm

Owning 49% shares,institutional owners seem interested in MiMedx Group, Inc. (NASDAQ:MDXG),

Simply Wall St.

6 months ago

Owning 49% shares,institutional owners seem interested in MiMedx Group, Inc. (NASDAQ:MDXG),

Castle Biosciences Presents Data Supporting the Utility of Its Tests in the Clinical Care of Patients with Skin Cancers at the 2024 Winter Clinical Dermatology Conference - Hawaii®

Business Wire

6 months ago

Castle Biosciences Presents Data Supporting the Utility of Its Tests in the Clinical Care of Patients with Skin Cancers at the 2024 Winter Clinical Dermatology Conference - Hawaii®

Steelcase (NYSE:SCS) shareholders have earned a 69% return over the last year

Simply Wall St.

6 months ago

Steelcase (NYSE:SCS) shareholders have earned a 69% return over the last year

AN2 Therapeutics Inc Chief Strategy Officer Kevin Krause Sells 7,417 Shares

GuruFocus.com

6 months ago

AN2 Therapeutics Inc Chief Strategy Officer Kevin Krause Sells 7,417 Shares

Eagle Point Credit Company Inc. Prices Offering of Preferred Stock

Business Wire

6 months ago

Eagle Point Credit Company Inc. Prices Offering of Preferred Stock

IMAX and Hyperobject Industries Join Forces to Head Into the Eye of the Storm with New Feature Documentary, "Stormbound"

PR Newswire

6 months ago

IMAX and Hyperobject Industries Join Forces to Head Into the Eye of the Storm with New Feature Documentary, "Stormbound"

Eagle Point Credit Company Inc. Announces Offering of Preferred Stock

Business Wire

6 months ago

Eagle Point Credit Company Inc. Announces Offering of Preferred Stock

The 7 Best REITs to Buy in January 2024

InvestorPlace

7 months ago

The 7 Best REITs to Buy in January 2024

Share on Social Networks: